RELX (formerly Reed Elsevier) is a publisher and information provider with activities in medical, legal and business publishing. Among the services it provides is Lexis-Nexis, the information provider.


Updates from The Motley Fool

Latest updates on RELX from Fool.com.


Stock Performance

REL vs. S&P 500 | 2 Year Performance
View Interactive REL Charts
Sponsored by

Key Data Points

Primary metrics and data points about RELX.
Current Price: $1,408.72
Prev Close: $1,397.00
Open: $1,397.00
Bid: $1,380.00
Ask: $1,420.00
Day's Range: $1,392.00 - $1,414.00
52wk Range: $631.02 - $1,436.00
Volume: 1,949,105
Avg Vol 3,848,039
Market Cap: $1,537.22B
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about RELX.
CAPS Rating 0 out of 5
 
0 Outperform
0 Underperform
CAPS All Stars
 
0 Outperform
0 Underperform

How do you think RELX will perform against the market?



You pick for RELX is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Erik Engstrom, CEO

79% Approve

Based on 11 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for RELX.

RELX (formerly Reed Elsevier) is a publisher and information provider with activities in medical, legal and business publishing. Among the services it provides is Lexis-Nexis, the information provider.

  • Exchange: LSE